Latest "Coventry Health Care Inc." News Stories

04:01 EDT 26th April 2018 | BioPortfolio

Here are the most relevant search results for "Coventry Health Care Inc." found in our extensive news archives from over 250 global news sources.

More Information about Coventry Health Care Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Coventry Health Care Inc. for you to read. Along with our medical data and news we also list Coventry Health Care Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Coventry Health Care Inc. Companies for you to search.

Showing "Coventry Health Care" News Articles 1–25 of 25,000+

Thursday 26th April 2018

Caretech Holdings Plc CTH Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

SummaryCaretech Holdings Plc CareTech is a social care provider that offers healthcare, special care and housing support services. The center offers solutions for adults such as learning disability, mental health, acquired brain injury, eating disorder, sensory impairments, autistic spectrum disorder, transition services, supported living, community support, residential support, and nursing and in...

Asklepios: An eventful 2017 financial year with sustained development

DGAP-News: Asklepios Kliniken / Key word(s): Final Results 26.04.2018 / 07:30 The issuer is solely responsible for the content of this announcement. Asklepios: An eventful 2017 financial year with sustained development Completion of Group restructuring under corporate law Group revenue at EUR 3,261.9 million and consolidated net profit at EUR 194.1 million. Investments in healthcar...

Rainbow Genomics Announces the Integration of Clinical Interpretation Services from the UCLA Clinical Genomics Center Supporting Whole Exome Sequencing Tests

The fully-integrated capabilities deliver whole exome sequencing tests covering cardio, adult and pediatric genetic disorders. Clinical reports based on clear medical evidence will be issued by U.S. board-certified medical directors at the UCLA Clinical Genomics Center. HONG KONG and SAN FRANCISCO (PRWEB) April 26, 2018 Hong Kong-based Rainbow Genomics announced the contracting of data analysis a...

Community Healthcare Initiatives are Discussed with Host Rob Lowe on "On Demand"

The importance of grass-roots initiatives are discussed in a new episode. (PRWEB) April 26, 2018 Loved by his fans for his good work, the successful actor Rob Lowe also uses his voice to educate society on issues affecting their day-to-day lives. The “On Demand” program he hosts provides important information to the society that has helped increase the understanding of modern issues. On an up...

Medibio Announces Scientific Advisory Board

Led by Board of Director Franklyn Prendergast, M.D., Ph.D. and Chief Medical Officer Archie Defillo, M.D. Key external members include Martin Chapman, M.D.; Joel Ehrenkranz, M.D.; Mark A. Frye, M.D.; Lawrence Hunter, Ph.D.; Wallace Mendelson, M.D.; Marie Casey Olseth, M.D., and Giampaolo Perna, M.D., Ph.D. SYDNEY, Australia and MINNEAPOLIS, April 25, 2018 (GLOBE NEWSWIRE) -- Medibio Limit...

Ipsen Reports Strong First Quarter 2018 Sales Growth of 23.1% at Constant Exchange Rates

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced its sales for the first quarter of 2018. Q1 2018 Financial highlights: Group sales growth of 23.1%, driven by Specialty Care sales growth of 27.4%, reflecting continued Somatuline® momentum an...

Wednesday 25th April 2018

R&D Successes Celebrated At 2018 CARE Awards

Informa Pharma Intelligence pays tribute to the people driving the advances in drug development and their commitments to advancing human...   

A clinical trial consortium takes root in Philadelphia

Members of the Partners in Innovation, Education, and Research consortium include Atlantic Health System, Drexel University, Einstein Healthcare Network, Geisinger including AtlantiCare, Main Line Health, and Thomas Jefferson University.

LMU Recognizes Gail Abarbanel with Honorary Degree for Support of Rape Victims

" Gail Abarbanelembodies the values of our Jesuit and Marymounttraditions, especially the cura personalis – the care for the whole person," said LMU Read more...

Market Access Teams Face New Challenges in Pharma

There are 6 key issues that market access teams are facing amid evolving marketplace trends in the pharmaceutical industry, said Douglas Long, BS, MBA, vice president, industry relations, IQVIA, when speaking at the headline session of the Academy of Managed Care Pharmacy's Managed Care & Specialty Pharmacy Annual Meeting held April 23-26, in Boston, Massachusetts. There are 6 key issues t...

EYPT Up 98% This Month, USNA In Good Health, MDXG To Report Q1 Results

EyePoint Pharmaceuticals gained 19.10% on Wednesday. The Company's NDA for YUTIQ micro-insert, proposed for treatment of non-infectious posterior segment uveitis, is under FDA review - with a decision expected on November 5, 2018.

Nanoscale sensor detects cytokine

A newly developed sensor can detect signalling molecules, called cytokines, which operate in the living brain. Cytokines in the brain are secreted by glia cells that make up nearly 90% of all brain cells. Cytokines play a central role in controlling mood and cognition and may also contribute to a number of mental health disorders. “What we’ve developed is the first sensor capable of monitori...

ASA survey: Drug shortages impact care for patients undergoing anesthesia

A national drug shortage crisis is potentially affecting the care received every day for thousands of patients undergoing anesthesia.

CU Anschutz Medical Campus receives NIH grant to speed up discovery of new treatments

The National Institutes of Health recently awarded $46.5 million to the University of Colorado Anschutz Medical Campus and its Colorado Clinical and Translational Sciences Institute, a research partnership designed to speed up development of new treatments to address the greatest health needs of Coloradans.

Bacteria enhance antifungal drug resistance in early childhood caries

Early childhood caries, a form of severe tooth decay affecting toddlers and preschoolers, can set children up for a lifetime of dental and health problems. The problem can be significant enough that surgery is the only effective way to treat it.

More US FDA Departures: ODE II Director Rosebraugh, GI Division Director Griebel to Retire

FDA will have three leadership positions vacant in the Office of Drug Evaluation II when Curtis Rosebraugh leaves at the...   

Witness the Eveline Smart Fertility System: iXensor will exhibit its mobile health solution at ACOG 2018 in Austin, Texas.

iXensor will join ACOG (Annual Clinical and Scientific Meeting) annual meeting to show a smartphone-based total solution for better care of women's health. TAIPEI, Taiwan, April 25, 2018 /PRNewswire/ -- iXensor, the leading mobile health provider, provides the PixoTest® technology that turns the front camera of the smartphone into an optical reader and al...

Greenbelt Greenhouse Ltd Recalls Greenbelt Microgreens Brand Microgreens Because of Possible Health Risk

Greenbelt Greenhouse LTD of British Columbia, Canada is recalling all Greenbelt Microgreen products with the best before dates from 4/24/18 and 4/31/18 because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.

New Mountain Capital Agrees to Sell Medical Specialties Distributors to McKesson

New Mountain Capital, LLC (“New Mountain”), a growth-oriented investment firm that currently manages more than $20 billion in assets, today announced that it has agreed to sell Medical Specialties Distributors (“MSD”) to McKesson Corporation. New Mountain acquired MSD in December 2013. MSD’s enterprise value approximately tripled during New Mountain’s...

Physio-Control Launches Newest Version of LUCAS Chest Compression System in United States

Latest version 3.1 provides powerful new capabilities for tailored setup functionality, wireless reporting and asset status notifications (Product Bulletin) Today Physio-Control, now part of Stryker, announced its newest version of the LUCAS® 3 Chest Compression System, version 3.1. The latest version provides powerful new capabilities for tailored de...

Global Health: Infant Deaths Fall Sharply in Africa With Routine Antibiotics

Providing one dose every six months saved one in four babies, researchers reported. Now the W.H.O. will consider recommending routine use.

Catabasis Pharmaceuticals Presents New Edasalonexent Data Showing Significantly Slowed Duchenne Muscular Dystrophy Disease Progression as Measured by MRI Through One Year of Treatment

-- Statistically Significant Improvements in MRI T2 Rate of Change Compared to Control Consistent with Improvements Demonstrated in Assessments of Muscle Function in MoveDMD® Trial -- Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage

Calyxt to Hold First Quarter 2018 Investor Conference Call on Tuesday, May 8, at 8 a.m. EDT – 7 a.m. CDT

Calyxt, Inc. (NASDAQ: CLXT), a consumer-centric, food- and agriculture-focused company, today announced the company will report financial results for the first quarter of 2018 on Monday, May 7, after the close of regular stock market trading hours. A conference call to discuss the company's results and its operations is scheduled on Tuesday, May 8, ...

Puma Biotechnology to Host Conference Call to Discuss First Quarter Financial Results

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Wednesday, May 9, 2018 following release of its first quarter 2018 financial results. The call may be accessed by dialing 1-877-709-8150 (domestic) or 1-201-689-8354 (international). Please dial in at least ten minut...

McKesson Launches Multi-Year Strategic Growth Initiative; Reaffirms Fiscal 2018 Outlook and Provides Preliminary Fiscal 2019 Outlook

McKesson announces a multi-year growth initiative, focused on creating innovative new solutions that improve patient care delivery and drive shareholder value. Fiscal 2018 Outlook: Adjusted Earnings of $12.50 to $12.80 per diluted share. Preliminary Fiscal 2019 Outlook: Adjusted Earnings of $13.00 to $1...

Quick Search


News Quicklinks